Presbyopia treatments | Patent Publication Number 20190321337

US 20190321337 A1
Patent NumberUS 10610518 B2
Application Number16393175
Filled DateApr 24, 2019
Priority DateApr 24, 2018
Publication DateOct 24, 2019
Original AssigneeAbbvie Inc.
Current AssigneeAllergan
Inventor/ApplicantsMohammed Dibas
Michael R. Robinson
Jihao Zhou
Anuradha Gore
Haixia Liu
Aileen Morgan
Jaya Giyanani
Sungwook Lee
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.